United States · FDA National Drug Code directory

Levothyroxine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68180-965_94052e3d-58b2-4f4b-8223-a47281c1a592
Product NDC: 68180-965
Form: TABLET
Composition / generic term: Levothyroxine Sodium
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190320
Source listing expiry: 20261231

Source-listed ingredients

LEVOTHYROXINE SODIUM — .025 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (68180-965-01) · 68180-965-01
1000 TABLET in 1 BOTTLE (68180-965-03) · 68180-965-03
90 TABLET in 1 BOTTLE (68180-965-09) · 68180-965-09

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →